X-Ray Inspection More Than Just Contamination Detection

June 3, 2019

This white paper looks at the potential of x-ray inspection to solve a wide range of product safety and quality control issues typically found within food and pharmaceutical manufacturing. It explores how x-ray inspection can detect faulty products before they leave the factory, avoiding product recalls and customer disappointment. It describes how in a single pass – and at high line speeds – x-ray systems can perform several inspection tasks simultaneously.

Spotlight

DeltaHealth China

DeltaHealth is an innovative healthcare provider primarily invested by Eight Roads and its affiliate Eight Roads Ventures China. As of now, it is also the first and the only medical institution with a consultation and advisory relationship with Columbia HeartSource in China. DeltaHealth is committed to establishing an integrated network of hospitals and clinics in China that specializes in cardiovascular care and always puts patients first. We aim to bring to our patients a set of innovative and personalized medical services. To achieve this, we are building on some of the great medical management practices in the West while combining the world's excellent physicians and state-of-the-art medical technology under one roof. In addition to providing diverse and high-quality healthcare services, we also strive to improve the diagnosis and treatment of cardiovascular diseases, and deliver better experience for patients. We see this as our contribution to the development of the medical syste

OTHER WHITEPAPERS
news image

A pragmatic approach to developing rare disease drug

whitePaper | July 13, 2023

Most medicines in development today target diseases affecting large sections of the global population. But now we are slowly beginning to see a rise in the interest of developing ”orphan drugs,” or pharmaceutical agents intended to treat rare diseases.

Read More
news image

Shining a Light on Lipid Nanoparticle Characterization

whitePaper | October 3, 2022

Next-Generation Synthetic Biology Workflow Platform Codex DNA’s BioXp 9600 system is a next-generation high throughput platform intended for automated synthesis of gene fragments and clones from digital sequences.

Read More
news image

MEETING CURRENT AND FUTURE SERIALISATIONCHALLENGES

whitePaper | December 5, 2022

Serialisation has emerged as a complex challenge for the pharmaceuticals sector which is facing a multiplicity of differing regulations that vary from one country to another.

Read More
news image

Assessing drug target association from biological evidences

whitePaper | July 7, 2022

The full drug target profile identification is many times a necessary step in drug development process. Recently, the move to a more holistic approach in drug discovery has resulted in the increasing use of cell-based assays to discover new biologically active small molecules.

Read More
news image

Why Deck 7

whitePaper | January 1, 2020

With over 2,800 campaigns each year delivered through a team of 300+ digital, data, and technology specialists, Deck 7 is a first resource for B2B demand generation services for marketers worldwide. Clients leverage Deck 7’s multichannel content marketing services and Media 7’s network of 30+ online publications for content syndication to engage over 95 million buyers across 16 industries and 120+ countries.

Read More
news image

Asia Pacific as a Clinical Trials Powerhouse

whitePaper | October 6, 2022

Patient availability is a critical component for clinical trials, and so it stands to reason that clinical development should match the epidemiology of diseases. Of course, this is often not the case,

Read More

Spotlight

DeltaHealth China

DeltaHealth is an innovative healthcare provider primarily invested by Eight Roads and its affiliate Eight Roads Ventures China. As of now, it is also the first and the only medical institution with a consultation and advisory relationship with Columbia HeartSource in China. DeltaHealth is committed to establishing an integrated network of hospitals and clinics in China that specializes in cardiovascular care and always puts patients first. We aim to bring to our patients a set of innovative and personalized medical services. To achieve this, we are building on some of the great medical management practices in the West while combining the world's excellent physicians and state-of-the-art medical technology under one roof. In addition to providing diverse and high-quality healthcare services, we also strive to improve the diagnosis and treatment of cardiovascular diseases, and deliver better experience for patients. We see this as our contribution to the development of the medical syste

Events